
Key Highlights from Macquarie’s Analysis:
- Demand & Pricing Recovery: Anticipated rebound in demand and potential price hikes are expected to strengthen margins in H2CY24.
- Focus on Cost Optimization: Industry-wide cost efficiency and capacity consolidation will support medium-term earnings growth.
- Capacity Utilization Trends: Steady utilization levels align with the expected demand recovery.
Stock Rating: UltraTech Cement: Outperform; Target Price ₹11,868. UltraTech remains Macquarie’s top pick in the sector.
Ultratech Cement Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Mon, Jan 20 2025
|
₹10,587.40
|
₹10,624.45
|
|
Fri, Jan 17 2025
|
₹10,636.20
|
₹10,580.00
|
-0.53%
|
Thu, Jan 16 2025
|
₹10,590.00
|
₹10,636.20
|
|
Wed, Jan 15 2025
|
₹10,540.00
|
₹10,521.65
|
|
Tue, Jan 14 2025
|
₹10,570.00
|
₹10,483.75
|
-1.24%
|
Mon, Jan 13 2025
|
₹10,700.00
|
₹10,615.15
|
-2.30%
|
Fri, Jan 10 2025
|
₹11,203.25
|
₹10,865.20
|
-3.50%
|
Thu, Jan 9 2025
|
₹11,403.55
|
₹11,259.80
|
-1.26%
|
Macquarie’s analysis highlights UltraTech Cement’s leadership and strong execution capabilities, which make it well-positioned to capitalize on sectoral recovery. Investors are advised to monitor pricing and demand trends as key growth drivers.
Disclaimer: This content is for informational purposes only and does not constitute financial advice. Please consult a financial advisor before making investment decisions.